This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
$1 buys you full access to ALL of TheStreet's Subscription Services! Learn More

Cardiome Pharma Corp (CRME)

NASDAQ: Health Care

Company Balance Sheet
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Assets
Cash and Equivalents 10.98M 41.27M 48.64M 76.89M
Receivables 6.67M 978.00K 1.25M 732.00K
Inventories 6.60M 0.00 0.00 0.00
Other Current Assets 0.00 0.00 0.00 0.00
Total Current Assets 28.33M 43.02M 50.52M 78.62M
Property, Plant & Equipment, Gross 1.23M 782.00K 8.40M 8.51M
Accumulated Depreciation & Depletion 615.00K 511.00K 6.44M 6.44M
Property, Plant & Equipment, Net 618.00K 271.00K 1.97M 2.07M
Intangibles 18.07M 1.51M 1.55M 1.64M
Other Non-Current Assets 0.00 0.00 0.00 0.00
Total Non-Current Assets 19.00M 1.78M 3.52M 3.70M
Liabilities & Shareholder Equity
Total Assets 47.33M 44.79M 54.04M 82.32M
Accounts Payable 6.45M 1.04M 351.00K 603.00K
Short Term Debt 0.00 32.50M 0.00 0.00
Other Current Liabilities 0.00 0.00 116.00K 216.00K
Total Current Liabilities 17.69M 36.93M 3.30M 5.92M
Long Term Debt 0.00 0.00 25.00M 25.00M
Deferred Income Taxes 7.00M 0.00 0.00 0.00
Other Non-Current Liabilities 0.00 0.00 445.00K 486.00K
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 7.00M 0.00 25.44M 25.49M
Total Liabilities 24.69M 36.93M 28.75M 31.41M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 22.64M 7.86M 25.29M 50.92M
Common Par 0.00 0.00 0.00 0.00
Additional Paid In Capital 305.43M 295.19M 294.30M 292.02M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -300.75M -305.52M -287.20M -259.28M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments 17.96M 18.18M 18.18M 18.18M
Total Capitalization 22.64M 7.86M 50.29M 75.92M
Total Equity 22.64M 7.86M 25.29M 50.92M
Total Liabilities & Stock Equity 47.33M 44.79M 54.04M 82.32M
Total Common Shares Outstanding 14.96M 12.47M 12.23M 12.21M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 12.77M 12.25M 12.23M 12.16M
Diluted Weighted Shares Outstanding 12.93M 12.25M 12.23M 12.26M
Number of Employees 75 13 92 79
Number of Part-Time Employees 0 0 0 0
CRME News

CRME Cardiome Pharma Corp

Analysts Ratings for CRME

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 0 0 0 0
Moderate Buy 2 2 2 2
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET CRME ANALYST REPORT

Brokerage Partners

CRME Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs